Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

KORU Medical Systems (KRMD) Shares Outstanding (2020 - 2025)

KORU Medical Systems has reported Shares Outstanding over the past 10 years, most recently at $49.8 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $49.8 million for Q4 2025, up 8.34% from a year ago — trailing twelve months through Dec 2025 was $49.8 million (up 8.34% YoY), and the annual figure for FY2025 was $49.8 million, up 8.34%.
  • Shares Outstanding for Q4 2025 was $49.8 million at KORU Medical Systems, roughly flat from $49.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for KRMD hit a ceiling of $49.8 million in Q4 2025 and a floor of $47.9 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $49.0 million (2023), compared with a mean of $48.9 million.
  • Biggest five-year swings in Shares Outstanding: rose 12.9% in 2021 and later dropped 6.38% in 2024.
  • KORU Medical Systems' Shares Outstanding stood at $48.0 million in 2021, then rose by 1.7% to $48.9 million in 2022, then rose by 0.47% to $49.1 million in 2023, then dropped by 6.38% to $46.0 million in 2024, then increased by 8.34% to $49.8 million in 2025.
  • The last three reported values for Shares Outstanding were $49.8 million (Q4 2025), $49.7 million (Q3 2025), and $49.7 million (Q2 2025) per Business Quant data.